Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-07-31 Sale |
2025-07-31 12:04 pm |
Sage Therapeutics Inc. | SAGE | Quirk Michael C. See Remarks |
32,961 | $0 | $0 | 0 (Direct) |
View |
2025-07-31 Sale |
2025-07-31 11:57 am |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
64,428 | $0 | $0 | 0 (Direct) |
View |
2025-07-31 Sale |
2025-07-31 11:22 am |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
23,735 | $0 | $0 | 0 (Direct) |
View |
2025-07-31 Sale |
2025-07-31 11:17 am |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
53,229 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-07-31 Equity Swap |
2025-07-31 11:48 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Barrett Elizabeth A. Director |
3,000 | $0 | 0 (Direct) |
View |
2025-07-31 Equity Swap |
2025-07-31 11:42 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Golumbeski George Director |
8,000 | $0 | 0 (Direct) |
View |
2025-07-31 Equity Swap |
2025-07-31 11:28 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director |
2,845 | $0 | 0 (Direct) |
View |
2025-07-31 Equity Swap |
2025-07-31 11:22 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
7,215 | $0 | 0 (Direct) |
View |
2025-07-31 Equity Swap |
2025-07-31 11:17 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
46,940 | $0 | 0 (Direct) |
View |
2025-06-24 Tax Withholding |
2025-06-26 4:02 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Quirk Michael C. See Remarks |
113 | $9.22 | 30,461 (Direct) |
View |
2025-06-24 Tax Withholding |
2025-06-26 4:02 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
79 | $9.22 | 30,950 (Direct) |
View |
2025-06-11 Option Award |
2025-06-13 4:14 pm |
N/A 2035-06-11 |
Sage Therapeutics Inc. | SAGE | Germano Geno J Director |
21,500 | $0 | 21,500 (Direct) |
View |
2025-06-11 Option Award |
2025-06-13 4:14 pm |
N/A 2035-06-11 |
Sage Therapeutics Inc. | SAGE | Golumbeski George Director |
21,500 | $0 | 21,500 (Direct) |
View |
2025-06-11 Option Award |
2025-06-13 4:13 pm |
N/A 2035-06-11 |
Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director |
21,500 | $0 | 21,500 (Direct) |
View |
2025-06-11 Option Award |
2025-06-13 4:13 pm |
N/A 2035-06-11 |
Sage Therapeutics Inc. | SAGE | Federer Jessica Director |
21,500 | $0 | 21,500 (Direct) |
View |
2025-06-11 Option Award |
2025-06-13 4:13 pm |
N/A 2035-06-11 |
Sage Therapeutics Inc. | SAGE | COLA MICHAEL F Director |
21,500 | $0 | 21,500 (Direct) |
View |
2025-06-11 Option Award |
2025-06-13 4:13 pm |
N/A 2035-06-11 |
Sage Therapeutics Inc. | SAGE | Barrett Elizabeth A. Director |
21,500 | $0 | 21,500 (Direct) |
View |
2025-04-10 Option Award |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
5,967 | $0 | 48,428 (Direct) |
View |
2025-04-10 Tax Withholding |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
1,454 | $6.91 | 48,428 (Direct) |
View |
2025-04-10 Option Award |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Quirk Michael C. See Remarks |
2,202 | $0 | 30,574 (Direct) |
View |
2025-04-10 Tax Withholding |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Quirk Michael C. See Remarks |
736 | $6.91 | 30,574 (Direct) |
View |
2025-04-10 Option Award |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
19,964 | $0 | 100,169 (Direct) |
View |
2025-04-10 Tax Withholding |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
4,862 | $6.91 | 100,169 (Direct) |
View |
2025-04-10 Option Award |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
525 | $0 | 31,029 (Direct) |
View |
2025-04-10 Tax Withholding |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
176 | $6.91 | 31,029 (Direct) |
View |
2025-04-01 Option Award |
2025-04-02 4:06 pm |
N/A 2035-03-31 |
Sage Therapeutics Inc. | SAGE | Quirk Michael C. See Remarks |
6,000 | $0 | 33,108 (Direct) |
View |
Ownership |
2025-04-02 4:06 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Quirk Michael C. See Remarks |
0 | $0 | 127,807 (Direct) |
View |
2025-03-24 Tax Withholding |
2025-03-26 4:36 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
79 | $8.21 | 30,680 (Direct) |
View |
2025-02-24 Tax Withholding |
2025-02-25 4:54 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
2,502 | $7.49 | 30,759 (Direct) |
View |
2025-02-13 Tax Withholding |
2025-02-14 4:27 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
822 | $7.18 | 43,915 (Direct) |
View |
2025-02-13 Tax Withholding |
2025-02-14 4:26 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Gault Laura Chief Medical Officer |
685 | $7.18 | 34,649 (Direct) |
View |
2025-02-13 Tax Withholding |
2025-02-14 4:26 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
627 | $7.18 | 33,261 (Direct) |
View |
2025-01-16 Option Award |
2025-01-21 4:12 pm |
N/A 2035-01-16 |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
42,000 | $0 | 61,888 (Direct) |
View |
2025-01-16 Option Award |
2025-01-21 4:11 pm |
N/A 2035-01-16 |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
174,000 | $0 | 174,000 (Direct) |
View |
2025-01-16 Option Award |
2025-01-21 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Gault Laura Chief Medical Officer |
24,000 | $0 | 35,334 (Direct) |
View |
2025-01-16 Option Award |
2025-01-21 4:11 pm |
N/A 2035-01-16 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
60,000 | $0 | 84,737 (Direct) |
View |
2025-01-03 Option Award |
2025-01-06 4:02 pm |
N/A 2035-01-03 |
Sage Therapeutics Inc. | SAGE | Golumbeski George Director |
13,593 | $0 | 13,593 (Direct) |
View |
2025-01-03 Option Award |
2025-01-06 4:02 pm |
N/A 2035-01-03 |
Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director |
19,154 | $0 | 19,154 (Direct) |
View |
2024-12-24 Tax Withholding |
2024-12-27 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
79 | $5.48 | 19,888 (Direct) |
View |
2024-11-01 Option Award |
2024-11-14 4:42 pm |
N/A 2034-11-01 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
18,750 | $0 | 37,237 (Direct) |
View |
2024-11-01 Option Award |
2024-11-01 4:24 pm |
N/A 2034-10-31 |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
15,000 | $0 | 29,967 (Direct) |
View |
Ownership |
2024-11-01 4:23 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
0 | $0 | 41,575 (Direct) |
View |
2024-08-05 Tax Withholding |
2024-08-07 4:05 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
12,273 | $8.96 | 85,067 (Direct) |
View |
2024-08-05 Option Award |
2024-08-07 4:05 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
50,400 | $0 | 85,067 (Direct) |
View |